Resultado de búsqueda
Hace 2 días · Takeda Nobuyoshi of Mito Domain: Concubine: Kageyama-dono: Youjuin: 1580: October 13, 1653: Masaki Yoritada (1551–1622) Hojo Ujitaka (d.1609)’s daughter: Tokugawa Yorinobu of Kishu Domain Tokugawa Yorifusa of Mito Domain: Concubine: Kotoku-no-Tsubone: Chōshō-in: 1548: January 10, 1620: Nagami Sadahide: Yuki Hideyasu of Fukui ...
15 de may. de 2024 · His clan, the Takeda, were already known to be devotees of the Suwa deity since the 12th century, when in 1140, Takeda Nobuyoshi donated lands to each of the two shrines of Suwa in thanksgiving for his defeat of the Taira.
- Unknown (circa 6th century?)
13 de may. de 2024 · May 13, 2024. Takeda to receive exclusive option to license global rights to ACI-24.060, a potential first-in-class active immunotherapy designed to delay or slow Alzheimer’s disease progression. AC Immune to receive upfront payment of $100 million upon closing and be eligible for an option exercise fee and additional potential ...
13 de may. de 2024 · Japan’s Takeda Pharmaceuticals has reached a deal worth up to $2.2bn to develop an Alzheimer’s vaccine made by Swiss start-up AC Immune, as drug companies race to invest in potentially ...
13 de may. de 2024 · MADRID, 13 May. (EUROPA PRESS) - La farmacéutica japonesa Takeda ha anunciado este lunes un acuerdo con la 'startup' sanitaria suiza AC Immune por hasta 2.200 millones de dólares (2.038 millones...
9 de may. de 2024 · OSAKA, Japan, May 9, 2024 – Takeda ( TSE:4502/NYSE:TAK ) today announced financial results for fiscal year 2023 (period ended March 31, 2024). Takeda delivered its Management Guidance for Core Operating Profit and exceeded its Management Guidance for Revenue and Core EPS performance at CER.
13 de may. de 2024 · May 13, 2024 23:46 JST. LONDON (Financial Times) -- Japan's Takeda Pharmaceutical has reached a deal worth up to $2.2 billion to develop an Alzheimer's vaccine made by Swiss startup AC Immune, as...
